Market Tracker

09/27 4:41pm ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

5.17
Delayed Data
As of 4:00pm ET
 +0.07 / +1.37%
Today’s Change
2.80
Today|||52-Week Range
7.80
+2.38%
Year-to-Date
No recent news for Keryx Biopharmaceuticals Inc.

Today’s Trading

Previous close5.10
Today’s open5.17
Day’s range5.07 - 5.21
Volume1,815,452
Average volume (3 months)1,630,869
Market cap$540.1M
Dividend yield--
Data as of 4:00pm ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)+3.25%
Earnings growth (this year)-2.96%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+26.37%
P/E ratioNM
Price/Sales38.35
Price/Book6.17

Competitors

 Today’s
change
Today’s
% change
ACRSAclaris Therapeutics...+0.22+0.88%
FLMLFlamel Technologies ...-0.36-2.69%
SCLNSciClone Pharmaceuti...-0.15-1.43%
RETAReata Pharmaceutical...+0.28+1.21%
Data as of 4:00pm ET, 09/27/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$13.7M
Annual profit (last year)-$123.1M
Net profit margin-900.18%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Gregory P. Madison
Chief Financial Officer
Scott A. Holmes
Corporate headquarters
Boston, Massachusetts

Forecasts